Abstract
The exclusion of women and racial minorities from research currently compromises the generalizability of findings. Native American women, are particularly underrepresented in clinical trials due to the complicated history between Native American health and the US government. Congress, the NIH, and the FDA are the most prominent actors involved in regulating the diversity of clinical trial participants. This article will identify and analyze the deficiencies of the current regulations promoting diversity in clinical trials and suggest some solutions to build community with Indigenous communities and promote their participation in clinical trials.
Recommended Citation
Alka Meresh,
Diversity Regulations for Clinical Trials & the Underrepresentation of Native American Women,
27
DePaul J. Health Care L.
(2026)
Available at:
https://via.library.depaul.edu/jhcl/vol27/iss1/3